Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Could this be a new era of preventative cancer medicine?

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

People are regaining weight rapidly after stopping popular weight loss injections, raising concerns about long-term ...

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...